Buy or sell Tempus stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Tempus Stock

Cancer battling operating system



Notable Investors

New Enterprise Associates


Chicago IL, US

Total Funding


About Tempus Stock

Tempus is a technology company that has built an operating system to battle cancer. It is on a mission to redefine how genomic data is used in a clinical setting. Their goal is for each patient to benefit from the treatment of others who came before by enabling physicians to deliver personalized cancer care for patients through interactive analytical and machine learning platform.


Funding History

September 2015$10.0M
June 2016$10.0M
November 2016$10.0M
April 2017$30.0M
September 2017$70.0M
March 2018$80.0M
August 2018$110M
May 2019$200M


Founder & Chief Executive Officer

Eric Lefkofsky

Chief Technology Officer

Shane Folley

Chief Operating Officer

Ryan Fukushima

Chief Medical Officer

Gary Palmer

Chief Financial Officer

Vanessa Rollings

Chief Commercial Officer

Mike Yasiejko

Chief Strategy Officer

Marc Yoskowitz

Chief Science Officer

Kevin White


Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Tempus or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 100K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: